Lyden, Patrick http://orcid.org/0000-0001-6170-4042
Broderick, Joseph
Grotta, James
Kwiatkowski, Thomas
Levine, Steven
Frankel, Michael
Haley, E. Clarke
Tilley, Barbara
Funding for this research was provided by:
NIH (N01-NS-02382, N01-NS-02374, N01-NS-02377, N01-NS-02381, N01-NS-02379, N01-NS-02373, N01-NS-02378, N01-NS-02376, N01-NS-02380)
Article History
Received: 8 November 2022
Accepted: 16 October 2023
First Online: 21 November 2023
Declarations
:
: Not applicable to this letter. Informed consent was obtained from all patients (or next-of-kin) enrolled in the NINDS rt-PA for Acute Ischemic Stroke.
: Not applicable.
: The authors confirm that they do not have, and have never had, any financial interest in the drug tissue plasminogen activator.